GEHC GE HealthCare
Permanent stock page ↗Health Care · S&P 500 · Nasdaq 100
Next earnings: not announced yet
What 27 analyst firms say about GE HealthCare: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
25 rated views · 28 analyst/firm records · 27 firms
Radar score
- S&P 500 · Top Picks · 6MNot scored · Average target is not above the current price
- S&P 500 · Safest consensus · 6MNot scored · Average target is not above the current price
Other indices (1)
- Nasdaq 100 · Top Picks · 6MNot scored · Average target is not above the current price
- Nasdaq 100 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 22 reports on GEHC from 15 analyst firms in the last 90 days (27 firms in the past year).
Comparing each firm's latest target with its previous one: 7 raised their price target, 1 lowered it, 2 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: UBS raised its target from $73.00 (set 31 Jul 2026) to $80.00 on 3 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | Buy | 4 Mar 2026 | 85.00 USD |
| Bank of America Securities | Craig Bijou | Hold | 5 Jan 2026 | 92.00 USD |
| Barclays | Christopher Pasquale | Buy | 29 Oct 2026 | 95.00 USD |
| BMO Capital Markets | Vikramjeet S Chopra | Hold | 8 Jul 2026 | Conflicting reports · excluded |
| BNP Paribas Exane | Navann Ty | Buy | 31 Jul 2026 | Conflicting reports · excluded |
| BTIG | Ryan Zimmerman | Buy | 28 Oct 2026 | 83.00 USD |
| Citigroup | Joanne Wuensch | Hold | 29 Oct 2026 | Conflicting reports · excluded |
| DBS | Nico Chen | Buy | 1 Jul 2026 | 100.00 USD |
| Evercore ISI | Vijay Kumar | Buy | 28 Oct 2026 | 84.00 USD |
| Goldman Sachs | David Roman | Hold | 8 Jun 2026 | 65.00 USD · 30 Apr 2026 |
| Hovde Group | Unnamed analyst | Hold | 17 Jul 2026 | 14.00 USD |
| HSBC | Unnamed analyst | — | 30 Apr 2026 | 90.00 USD |
| Jefferies | Matthew C Taylor | Buy | 29 Oct 2026 | 95.00 USD |
| JPMorgan | Robbie Marcus | Hold | 29 Oct 2026 | 80.00 USD |
| Mizuho | Anthony Petrone | Buy | 29 Oct 2026 | 90.00 USD |
| Morgan Stanley | Patrick Wood | Hold | 4 Feb 2026 | 85.00 USD |
| Needham | David Saxon | Buy | 5 Oct 2026 | 93.00 USD |
| Oppenheimer | Suraj Kalia | Buy | 30 Jul 2026 | — |
| Piper Sandler | Jason Bednar | Buy | 28 Oct 2026 | — |
| RBC Capital Markets | Kendall Au | Buy | 29 Oct 2026 | 90.00 USD |
| RBC Capital Markets | Shagun Singh | Buy | 5 Oct 2026 | — |
| Redburn | Ed Ridley-Day | Buy | 31 Jul 2026 | Conflicting reports · excluded |
| Stifel | Unnamed analyst | — | 29 Apr 2026 | 80.00 USD |
| UBS | Graham Doyle | Hold | 31 Jul 2026 | 73.00 USD |
| Weiss Ratings | Unnamed analyst | — | 6 Oct 2026 | — |
| Wells Fargo | Larry Biegelsen | Buy | 30 Jul 2026 | 85.00 USD |
| Wolfe Research | Mike Polark | Hold | 20 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 11 Aug 2026 | 71.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.